Asiatic Laboratories Statistics
Total Valuation
Asiatic Laboratories has a market cap or net worth of BDT 4.15 billion.
Market Cap | 4.15B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Saturday, November 30, 2024.
Earnings Date | Nov 30, 2024 |
Ex-Dividend Date | Nov 21, 2024 |
Share Statistics
Asiatic Laboratories has 122.39 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 122.39M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 55.71% |
Owned by Institutions (%) | 1.63% |
Float | 46.08M |
Valuation Ratios
The trailing PE ratio is 11.09.
PE Ratio | 11.09 |
Forward PE | n/a |
PS Ratio | 2.02 |
PB Ratio | 0.57 |
P/TBV Ratio | 0.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.73 |
Quick Ratio | 0.92 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.76 |
Debt / FCF | n/a |
Interest Coverage | 10.13 |
Financial Efficiency
Return on equity (ROE) is 5.26% and return on invested capital (ROIC) is 4.74%.
Return on Equity (ROE) | 5.26% |
Return on Assets (ROA) | 4.29% |
Return on Capital (ROIC) | 4.74% |
Revenue Per Employee | 1.90M |
Profits Per Employee | 345,632 |
Employee Count | 777 |
Asset Turnover | 0.24 |
Inventory Turnover | 2.40 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 32.95 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 50.64 |
Average Volume (20 Days) | 1,805,180 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Asiatic Laboratories had revenue of BDT 1.47 billion and earned 268.56 million in profits. Earnings per share was 3.06.
Revenue | 1.47B |
Gross Profit | 637.39M |
Operating Income | 415.63M |
Pretax Income | 375.76M |
Net Income | 268.56M |
EBITDA | 504.82M |
EBIT | 415.63M |
Earnings Per Share (EPS) | 3.06 |
Balance Sheet
The company has 7.89 million in cash and 381.96 million in debt, giving a net cash position of -374.08 million or -3.06 per share.
Cash & Cash Equivalents | 7.89M |
Total Debt | 381.96M |
Net Cash | -374.08M |
Net Cash Per Share | -3.06 |
Equity (Book Value) | 5.24B |
Book Value Per Share | 59.68 |
Working Capital | 537.46M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 43.28%, with operating and profit margins of 28.22% and 18.23%.
Gross Margin | 43.28% |
Operating Margin | 28.22% |
Pretax Margin | 25.51% |
Profit Margin | 18.23% |
EBITDA Margin | 34.28% |
EBIT Margin | 28.22% |
FCF Margin | n/a |
Dividends & Yields
Asiatic Laboratories does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 9.02% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Asiatic Laboratories has an Altman Z-Score of 1.12. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.12 |
Piotroski F-Score | n/a |